Jim Gearhart

by Jim Gearhart

Week in Review (March 13, 2015)

The NIH reports on a possible breakthrough in understanding the genetics of inherited Alzheimer’s

The Wall Street Journal’s Pharmalot blog looks at a government report that suggests DEA policies contribute to prescription drug shortages.

NIH is working out its plans for sharing data to support the personalized medicine initiative.

Researchers want the next organ on a chip to be the human heart.

After gaining GSK’s oncology section, Novartis anticipates cost cuts.

Producing Biosimilars: Amgen Couldn’t Beat ‘em, so It Joins ‘em.

A couple of weeks ago, NPR’s Radiolab had a segment about Facebook’s behavioral research. It’s an interesting perspective on last year’s Social Contagion story.

Fierce BioTech discusses the trend of R&D layoffs at big pharma.

Tags: , ,